Quote:
Originally Posted by AlexanderHanff
Another point worth revisiting is the 32M GBP they are expecting to raise in share deals with Morgan Stanley. The deal was I think 1.6M shares at 32M with Canaccord Adams Ltd. and Morgan Stanley with shares placed at 20GBP per share. At the moment the market price is about £12.80 per share.
I wonder how these two new investors are feeling given they entered a deal which has devalued by 40% before it has even been finalised. Do we still think these 2 investors are going to go through with it? Given that the money raised is earmarked for actually setting up the system in the UK, it could prove disastrous for Phorm if they back out at the last hurdle.
Alexander Hanff
|
Unfortunately the placing has closed people. Don't you just feel awful for the the people who paid £ 20 a share for a stake in Phorm.
On to pressing business. There was a very good point made earlier in the thread that the battle has been won but the war has not.
So with that in mind.
Alex: any research I can help with in preparation for the interview you are doing next week post it up or PM.
Private discussion area. It might be worth setting up a non public access thread somewhere if possible.
Judicial review - a quick skim of the info suggests it might be possible. What are everyone elses thoughts?